Cytosorbents Corporation

US$4.80As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CTSOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (27.35%)
Div yield —
ROE (336.21%)
Medical Devices
Beta (5Y) 1.48
PE TTM —
TSR TTM (69.81%)
Mkt cap US$15.13M
ROIC (21.86%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.30
10.40%
(22.84%)
Sell 2|1|1|4|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.06
17.80%
14.68%
5.02%
8.36%
Revenue$M
0.999
1.031
1.079
1.112
6.48%
7.62%
13.25%
11.82%
Peers (US$15.13M)
Cap (US$)
PE
18.84M
2.801x
13.58M
—
Capital
TTM
5Y
10Y
Leveragex
0.594
0.086
0.089
EBIT/Intx
0.246
2.705
2.299
Own earn%
(23.35)
(26.16)
(33.53)
Sh yield%
33.42
43.69
40.99
Owners
Insiders/Inst%
5.69
72.13
Short interest%
5.11
SBC / revenue%
1.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
6–19
$1 testx
−0.4
Incr. ROIC%
14